From: Higher dietary fat quality is associated with lower anxiety score in women: a cross-sectional study

Q1 ( n = 60) | Q2 ( n = 60) | Q3 ( n = 60) | Q4 ( n = 60) | Q5 ( n = 60) | p-trend | |
---|---|---|---|---|---|---|

Total fat (non-case/case) | (43/17) | (39/21) | (35/25) | (32/28) | (38/22) | |

Model 1 | 1.00 | 1.36 (0.62–2.94) | 1.80 (0.84–3.86) | 2.21 (1.03–4.71) | 1.46 (0.67–3.15) | 0.1 |

P-value | 0.4 | 0.1 | 0.1 | 0.4 | ||

Model 2 | 1.00 | 1.23 (0.55–2.73) | 1.77 (0.79–3.96) | 1.81 (0.82–3.98) | 1.20 (0.56–2.66) | 0.4 |

P-value | 0.6 | 0.1 | 0.1 | 0.6 | ||

SFAs (non-case/case) | (44/16) | (43/17) | (35/25) | (37/23) | (28/32) | |

Model 1 | 1.00 | 1.08 (0.48–2.42) | 1.96 (0.91–4.23) | 1.66 (0.76–3.60) | 3.25 (1.51–7.02) | 0.001 |

P-value | 0.8 | 40.08 | 0.1 | 0.003 | ||

Model 3: model 2 + MUFAs, PUFAs, Trans | 1.00 | 1.36 (0.59–3.12) | 2.12 (0.96–4.69) | 1.66 (0.75–3.70) | 3.17 (1.43–7.00) | 0.005 |

P-value | 0.4 | 0.06 | 0.2 | 0.004 | ||

MUFAs (non-case/case) | (29/31) | (38/22) | (39/21) | (39/22) | (42/17) | |

Model 1 | 1.00 | 0.54 (0.26–1.12) | 0.50 (0.24–1.04) | 0.52 (0.25–1.09) | 0.37 (0.17–0.80) | 0.02 |

P-value | 0.6 | 0.6 | 0.02 | 0.2 | ||

Model 4: model 2 + SFAs, PUFAs, Trans | 1.00 | 0.41 (0.19–0.90) | 0.36 (0.16–0.82) | 0.34 (0.15–0.77) | 0.15 (0.05–0.44) | 0.001 |

P-value | 0.02 | 0.01 | 0.01 | 0.001 | ||

Oleic acid (non-case/case) | (25/35) | (38/22) | (40/20) | (41/19) | (43/17) | |

Model 1 | 1.00 | 0.42 (0.20–0.88) | 0.34 (0.16–0.73) | 0.33 (0.15–0.69) | 0.28 (0.13–0.60) | 0.001 |

P-value | 0.02 | 0.005 | 0.004 | 0.001 | ||

Model 4: model 2 + SFAs, PUFAs, Trans | 1.00 | 0.43 (0.20–0.92) | 0.33 (0.15–0.72) | 0.28 (0.12–0.64) | 0.25 (0.09–0.67) | 0.002 |

P-value | 0.03 | 0.006 | 0.002 | 0.006 | ||

PUFAs (non-case/case) | (32/28) | (39/21) | (44/16) | (30/30) | (42/18) | |

Model 1 | 1.00 | 0.61 (0.29–1.28) | 0.41 (0.19–0.89) | 1.14 (0.55–2.34) | 0.49 (0.23–1.03) | 0.3 |

P-value | 0.1 | 0.02 | 0.7 | 0.06 | ||

Model 5: model 2 + SFAs, MUFAs, Trans | 1.00 | 0.96 (0.41–2.23) | 1.71 (0.72–4.05) | 2.35 (0.99–5.58) | 1.49 (0.53–4.14) | 0.1 |

P-value | 0.9 | 0.2 | 0.052 | 0.4 | ||

Dietary cholesterol (non-case/case) | (42/18) | (34/26) | (41/19) | (38/22) | (32/28) | |

Model 1 | 1.00 | 1.78 (0.84–3.78) | 1.08 (0.49–2.34) | 1.35 (0.63–2.89) | 2.04 (0.96–4.32) | 0.1 |

P-value | 0.1 | 0.8 | 0.4 | 0.06 | ||

Model 6: model 2 + SFAs, PUFAs, MUFAs, Trans | 1.00 | 1.91 (0.83–4.41) | 0.92 (0.38–2.22) | 0.93 (0.38–2.20) | 0.98 (0.39–2.50) | 0.4 |

P-value | 0.2 | 0.5 | 0.6 | 0.7 | ||

n-3 PUFAs (non-case/case) | (36/24) | (35/25) | (47/13) | (32/28) | (37/23) | |

Model 1 | 1.00 | 1.07 (0.51–2.21) | 0.41 (0.18–0.92) | 1.31 (0.63–2.70) | 0.93 (0.44–1.94) | 0.9 |

P-value | 0.8 | 0.03 | 0.4 | 0.8 | ||

Model 7: model 2 + SFAs, MUFAs, Trans, n-6 | 1.00 | 1.05 (0.46–2.40) | 0.37 (0.15–0.94) | 0.92 (0.38–2.26) | 0.66 (0.21–2.04) | 0.4 |

P-value | 0.8 | 0.03 | 0.8 | 0.4 | ||

ALA (non-case/case) | (24/36) | (35/25) | (28/32) | (46/14) | (54/6) | |

Model 1 | 1.00 | 0.44 (0.21–0.92) | 0.73 (0.35–1.51) | 0.18 (0.08–0.40) | 0.08 (0.03–0.21) | < 0.001 |

P-value | 0.02 | 0.3 | < 0.001 | < 0.001 | ||

Model 7: model 2 + SFAs, MUFAs, Trans, n-6 | 1.00 | 0.34 (0.15–0.79) | 0.59 (0.25–1.39) | 0.14 (0.05–0.37) | 0.07 (0.02–0.23) | < 0.001 |

P-value | 0.6 | 0.6 | 0.1 | < 0.001 | ||

DHA (non-case/case) | (34/26) | (38/22) | (39/21) | (32/28) | (44/16) | |

Model 1 | 1.00 | 0.75 (0.36–1.57) | 0.70 (0.33–1.47) | 1.14 (0.55–2.35) | 0.47 (0.22–1.02) | 0.2 |

P-value | 0.4 | 0.3 | 0.7 | 0.05 | ||

Model 7: model 2 + SFAs, MUFAs, Trans, n-6 | 1.00 | 0.77 (0.34–1.73) | 0.94 (0.41–2.15) | 1.29 (0.57–2.90) | 0.59 (0.25–1.40) | 0.6 |

P-value | 0.5 | 0.8 | 0.5 | 0.2 | ||

EPA (non-case/case) | (33/27) | (39/21) | (37/23) | (36/24) | (42/18) | |

Model 1 | 1.00 | 0.65 (0.31–1.37) | 0.76 (0.36–1.57) | 0.81 (0.39–1.68) | 0.52 (0.24–1.11) | 0.2 |

P-value | 0.2 | 0.4 | 0.5 | 0.09 | ||

Model 7: model 2 + SFAs, MUFAs, Trans, n-6 | 1.00 | 0.63 (0.27–1.44) | 0.93 (0.41–2.12) | 0.78 (0.35–1.75) | 0.62 (0.26–1.48) | 0.4 |

P-value | 0.2 | 0.8 | 0.5 | 0.2 | ||

n-6 PUFAs (non-case/case) | (40/20) | (40/20) | (35/25) | (34/26) | (38/22) | |

Model 1 | 1.00 | 1.00 (0.46–2.13) | 1.42 (0.68–3.00) | 1.52 (0.72–3.20) | 1.15 (0.54–2.45) | 0.4 |

P-value | 1.0 | 0.3 | 0.2 | 0.7 | ||

Model 8: model 2 + SFAs, MUFAs, Trans, n-3 | 1.00 | 0.89 (0.37–2.10) | 1.56 (0.65–3.71) | 1.61 (0.65–4.00) | 1.24 (0.38–4.08) | 0.3 |

P-value | 0.7 | 0.3 | 0.2 | 0.7 | ||

n-3: n-6 (non-case/case) | (34/26) | (33/27) | (33/27) | (47/13) | (40/20) | |

Model 1 | 1.00 | 1.07 (0.5–2.2) | 1.07 (0.5–2.2) | 0.3 (0.16–0.80) | 0.6 (0.31–1.37) | 0.02 |

P-value | 0.85 | 0.85 | 0.01 | 0.26 | ||

Model 5: model 2 + SFAs, MUFAs, Trans | 1.00 | 0.97 (0.42–2.23) | 0.94 (0.41–2.17) | 0.36 (0.15–0.88) | 0.56 (0.24–1.03) | 0.02 |

P-value | 0.9 | 0.9 | 0.02 | 0.1 |